GRIS-PEG Drug Patent Profile
✉ Email this page to a colleague
When do Gris-peg patents expire, and what generic alternatives are available?
Gris-peg is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in GRIS-PEG is griseofulvin, ultramicrosize. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the griseofulvin, ultramicrosize profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Gris-peg
A generic version of GRIS-PEG was approved as griseofulvin, ultramicrosize by MOUNTAIN on January 9th, 2014.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GRIS-PEG?
- What are the global sales for GRIS-PEG?
- What is Average Wholesale Price for GRIS-PEG?
Summary for GRIS-PEG
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 52 |
| Patent Applications: | 109 |
| Drug Prices: | Drug price information for GRIS-PEG |
| What excipients (inactive ingredients) are in GRIS-PEG? | GRIS-PEG excipients list |
| DailyMed Link: | GRIS-PEG at DailyMed |
US Patents and Regulatory Information for GRIS-PEG
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch | GRIS-PEG | griseofulvin, ultramicrosize | TABLET;ORAL | 050475-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Bausch | GRIS-PEG | griseofulvin, ultramicrosize | TABLET;ORAL | 050475-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
